DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Ausgabe 06 · Volume 62 · 1989 DOI: 10.1055/s-009-45136

Review Article

648
Thomas, Duncan P: Biologicals, Standards and Heparin

Original Article

651
Tran-Thang, Chiên; Fasel-Felley, Josette; Pralong, Gerard; Hofstetter, Jean-René; Bachmann, Fedor; Kruithof, Egbert K O: Plasminogen Activators and Plasminogen Activator Inhibitors in Liver Deficiencies Caused by Chronic Alcoholism or Infectious Hepatitis
654
Hasselaar, Paula; Derksen, Ronald H W M; Oosting, Janine D; Blokzijl, Laya; de Groot, Philip G: Synergistic Effect of Low Doses of Tumor Necrosis Factor and Sera from Patients with Systemic Lupus Erythematosus on the Expression of Procoagulant Activity by Cultured Endothelial Cells
661
Al-Mondhiry, Hamid; Wallin, Reidar: Synthesis of Vitamin K-Dependent Proteins by Cultured Human Tumor Cells
667
Otter, M; Van Berkel, Th J C; Rijken, D C: Binding and Degradation of Tissue-Type Plasminogen Activator by the Human Hepatoma Cell Line Hep G2
673
Engesser, L; Brommer, E J P; Kluft, C; Briët, E: Elevated Plasminogen Activator Inhibitor (PAI), a Cause of Thrombophilia? – A Study in 203 Patients with Familial or Sporadic Venous Thrombophilia
681
Boissel, J P; Peyrieux, J C; Destors, J M: Is It Possible to Reduce the Risk of Cardiovascular Events in Subjects Suffering from Intermittent Claudication of the Lower Limbs?
686
Levi, Marcel; ten Cate, Jan W; Dooijewaard, Gerard; Sturk, Augueste; Brommer, Emile J P; Agnelli, Giancarlo: DDAVP Induces Systemic Release of Urokinase-Type Plasminogen Activator
690
López-Fernández, M F; López-Berges, C; Fermoso, J; Martín-Pascual, A; Sánchez-Hernández, J J; López-Borrasca, A; Batlle, J: High Levels of Plasma FVIII and vWF in the Toxic Epidemic Syndrome Patients
694
Gómez, C; Páramo, J A; Colucci, M; Rocha, E: Effect of Heparin and/or Antithrombin III on the Generation of Endotoxin-Induced Plasminogen Activator Inhibitor
699
Aerts, Rob J; Gillis, Karin; Pannekoek, Hans: Single-Chain and Two-Chain Tissue-Type Plasminogen Activator (t-PA) Bind Differently to Cultured Human Endothelial Cells
704
Ogilvie, Mary L; Byl, JoAnn Wilson; Gartner, T Kent: Platelet Aggregation Is Stimulated by Lactose-lnhibitable Snake Venom Lectins
708
Marcovina, Santica; Coppola, Raffaella; Valsecchi, Carla; Zoppo, Adele; Gelfi, Cecilia; Mannucci, Pier Mannuccio: Monoclonal Antibodies Directed to the Calcium-Free Conformation of Human Protein S
715
Brenner, B; Zwang, E; Bronshtein, M; Seligsohn, U: Von Willebrand Factor Multimer Patterns in Pregnancy-Induced Hypertension
718
Behnke, O: Coated Pits and Vesicles Transfer Plasma Components to Platelet Granules
723
Kooistra, T; Bosma, P J; Töns, H A M; van den Berg, A P; Meyer, P; Princen, H M G: Plasminogen Activator Inhibitor 1: Biosynthesis and mRNA Level Are Increased by Insulin in Cultured Human Hepatocytes
729
Kumar, S; Haigh, J R M; Rhodes, L E; Peaker, S; Davies, J A; Roberts, B E; Feely, M P: Poor Compliance Is a Major Factor in Unstable Outpatient Control of Anticoagulant Therapy
733
Wong, Truman; Pedvis, Lloyd; Frojmovic, Mony: Platelet Size Affects both Micro- and Macro-Aggregation: Contributions of Platelet Number, Volume Fraction and Cell Surface
742
Stigbrand, Torgny; Frängsmyr, Lars; Bergsdorf, Nils; Wallen, Per: Characterization of Monoclonal Antibodies to Human Tissue-Type Plasminogen Activator: Catalytic Inhibition and One-Two Chain Discriminatory Reactivities
748
Lindahl, Tomas L; Sigurdardottir, Olöf; Wiman, Björn: Stability of Plasminogen Activator Inhibitor 1 (PAI-1)
752
Rydzewski, Andrzej; Takada, Yumiko; Takada, Akikazu: Stimulation of Plasmin Catalyzed Conversion of SingleChain to Two-Chain Urokinase-Type Plasminogen Activator by Sulfated Polysaccharides
756
van der Meer, Felix J M; van Tilburg, Nico H; van Wijngaarden, Aat; van der Linden, Irma K; Briët, Ernest; Bertina, Rogier M: A Second Plasma Inhibitor of Activated Protein C: α1-Antitrypsin
763
Mannucci, P M; Valsecchi, C; Krachmalnicoff, A; Faioni, E M; Tripodi, A: Familial Dysfunction of Protein S
767
Jern, Christina; Eriksson, Elsa; Tengborn, Lilian; Risberg, Bo; Wadenvik, Hans; Jern, Sverker: Changes of Plasma Coagulation and Fibrinolysis in Response to Mental Stress
772
Kirschstein, W; Simianer, S; Dempfle, C E; Keller, H; Stegaru, B; Rentrop, P; Heene, D L: Impaired Fibrinolytic Capacity and Tissue Plasminogen Activator Release in Patients with Restenosis after Percutaneous Transluminal Coronary Angioplasty (PTCA)
776
Wilson, J; Orchard, M A; Spencer, A A; Davies, J A; Prentice, C R M: Anti-Hypertensive Drugs Non-Specifically Reduce “Spontaneous” Activation of Blood Platelets
781
Tomita, Yukiharu; Harrison, Janet; Abildgaard, Charles F: von Willebrand Factor Multimer Analysis Using a Sensitive Peroxidase Staining Method
784
Pina-Cabral, J M; Cunha-Monteiro, A; Sousa-Dias, M C; Andrade, J A: Effect of Propranolol, Barbiturate Anesthesia and Splenectomy on Factor VIII: C and Plasminogen Activator Release Induced by DDAVP
788
Xi, Ma; Béguin, S; Hemker, H C: The Relative Importance of the Factors II, VII, IX and X for the Prothrombinase Activity in Plasma of Orally Anticoagulated Patients
792
Kluft, C; Los, P; Clemmensen, I; Brommer, E J P; Gevers Leuven, J A; Boks, A L; Vellenga, E: Quantitation of Plasma Levels of Tetranectin - Effects of Oral Contraceptives, Pregnancy, Treatment with L-Asparaginase and Liver Cirrhosis
797
Berg Schmidt, E; Ernst, E; Varming, K; Pedersen, J O; Dyerberg, J: The Effect of n-3 Fatty Acids on Lipids and Haemostasis in Patients with Type lla and Type IV Hyperlipidaemia
802
de Graaf, Jacques C; Bult, Hidde; de Meyer, Guido R Y; Sixma, Jan J; de Groot, Philip G: Platelet Adhesion to Subendothelial Structures under Flow Conditions: No Effect of the Lipoxygenase Product 13-HODE

Scientific and Standardization Committee Communications

807
Owen, John: The Utility of Plasma Fibrinopeptide Assays
813
Francis, Charles W; Mosesson, Michael W: Terminology for Fibrinogen γ-Chains Differing in Carboxyl Terminal Amino Acid Sequence

Guidelines for SSC Communications

811
Brettler, Doreen B: Proposed Protocol for the Evaluation of the Effect of High Purity Factor Concentrates on the Immune System of Hemophilia Patients

Letters to the Editor

815
Zucker, Marjorie B; Grant, Robert A; Mauss, Evelyn A: Failure of 6D1 or Exposure of Platelets to ADP to Affect Agglutination Induced by Wheat Germ Agglutinin
816
Hanss, M; Martoia, R; Horellou, M H; Samama, M: Severe Acquired Deficiency of Vitamin K-Dependent Factors and Resistance to Multiple Vitamin K Injections
817
Lefrére, J J; Conard, J; Lerable, J; Samama, M: Antithrombin III and Hepatocellular Carcinoma
818
Hermán, Ferenc; Magyar, Kálmán; Kovács, Katalin; Filep, János: Decreased Sensitivity of Platelets to Platelet-Activating Factor in Migraine Patients During the Headache-Free Interval
819
Mannucci, P M; Cugno, M; Mameli, G; Marongiu, F: Fibrin(ogen) Peptides in Early Breast Cancer
820
De Stefano, Valerio; Leone, Giuseppe: Antithrombin III Congenital Defects: Revising Classification System